Work

Improved humoral immunogenicity with mRNA‐1273 versus BNT162b2 as third vaccine dose among solid organ transplant recipients seronegative after two BNT162b2 doses

Year: 2022

Type: article

Source: Clinical Transplantation

DOI: 10.1111/ctr.14738

Authors: Amy Chang, Teresa PY. Chiang, Jake D. Kim, Jonathan Mitchell, Jennifer L. Alejo, Alexa A. Jefferis, Robin K. Avery, Aaron A. R. Tobian, Macey L. Levan, Daniel S. Warren, Jacqueline M. Garonzik‐Wang, Allan B. Massie, Dorry L. Segev, William A. Werbel

Institutions: Johns Hopkins University, Johns Hopkins Medicine, New York University, University of Wisconsin–Madison

Language: English

Topic: SARS-CoV-2 and COVID-19 Research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: American Society of Transplant Surgeons, National Institutes of Health, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G1158395370, G1617831573, G1644439105, Renal Disease Epidemiology Training Grant, G4034955770, G4224651719, G4275821947, G440660051, G5167178993, G5985342825, G636120516, G6925492526, G6973996005, G7864266139, Expanding HOPE Liver Transplantation: Understanding Opportunistic Infection and Cancer Risk, Clinical and Laboratory Research Training for Gastrointestinal Surgeons

OpenAlex ID: W4281967096

FWCI: 0.226

Cites: 5

Cited by: 2

Related to: 10